NGeneBio (Korea) Today
| 354200 Stock | KRW 3,360 55.00 1.61% |
Performance0 of 100
| Odds Of DistressLess than 38
|
NGeneBio is trading at 3360.00 as of the 10th of June 2024, a -1.61 percent down since the beginning of the trading day. The stock's open price was 3415.0. NGeneBio has about a 38 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for NGeneBio Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 11th of May 2024 and ending today, the 10th of June 2024. Click here to learn more.
NGeneBio Co., Ltd. develops in vitro diagnostics companion diagnostics products and bioinformatics software. The company was founded in 2015 and is headquartered in Seoul, South Korea. NGeneBio is traded on Korean Securities Dealers Automated Quotations in South Korea. More on NGeneBio Co
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
NGeneBio Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. NGeneBio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding NGeneBio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
NGeneBio Co (354200) is traded on KOSDAQ in Korea . The company currently falls under 'Mega-Cap' category with a current market capitalization of 124.13 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NGeneBio's market, we take the total number of its shares issued and multiply it by NGeneBio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. NGeneBio operates under Healthcare sector and is part of Biotechnology industry.
NGeneBio Co has accumulated about 16.3 B in cash with (7.52 B) of positive cash flow from operations.
Check NGeneBio Probability Of Bankruptcy
Ownership AllocationThe market capitalization of NGeneBio Co is currently W124.13 Billion. NGeneBio Co holds large amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Be advised that no matter how volatile the entity is, if the real value of the firm is more than the value suggested by the market, you should consider buying it.
Check NGeneBio Ownership Details
NGeneBio Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. NGeneBio market risk premium is the additional return an investor will receive from holding NGeneBio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in NGeneBio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although NGeneBio's alpha and beta are two of the key measurements used to evaluate NGeneBio's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.55 | |||
| Standard Deviation | 5.74 | |||
| Variance | 32.99 | |||
| Risk Adjusted Performance | (0.03) |
NGeneBio Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in NGeneBio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
Other Information on Investing in NGeneBio Stock
NGeneBio financial ratios help investors to determine whether NGeneBio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NGeneBio with respect to the benefits of owning NGeneBio security.